Concepedia

Raj Kumar Shirumalla

RK

Statistics

Publications

5

Citations

204

H-Index

5

Active since

2006

Affiliations

Aurobindo Pharma (United States)(Current)

Raj Kumar Shirumalla is an author at Aurobindo Pharma (United States) specializing in pharmacology, medicine, and medicinal plants.

ORCID

Publications per year

2006–2015

5

Publications

5

Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type‐2 diabetes

Sameer Sharma, Chandra Sekhar Misra, Surendar Arumugam et al. · Phytotherapy Research · 2010 · 88 citations

, , +14

Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes

Ruchi Sood, Rajendra Raut, Poornima Tyagi et al. · PLoS neglected tropical diseases · 2015 · 79 citations · Full text

, , +17

Ranbezolid, a novel oxazolidinone antibacterial: In vivo characterisation of monoamine oxidase inhibitory potential in conscious rats

Krishna S. Naruganahalli, Raj Kumar Shirumalla, Vimal Bansal et al. · European Journal of Pharmacology · 2006 · 14 citations

, , +12

Ceramide kinase: a potential anti-inflammatory target?

Shweta Saxena, Manish Banerjee, Raj Kumar Shirumalla et al. · PubMed · 2008 · 13 citations

, , +16

Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase

Puneet Chopra, Onkar P. Kulkarni, Shashank Gupta et al. · International Immunopharmacology · 2010 · 10 citations

, , +11

1–5 of 5